The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Lachey Jennifer since 2021.
This trader's CIK number is 1808322.
At the time of last reporting, Lachey Jennifer was the Chief Scientific Officer of Keros Therapeutics, Inc.. (stock ticker symbol KROS).
Also see all insider trading activities at Keros Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2022 | KROS | 0 | $0 | 77,100 | $3,058,894 | 86,500 | $25,949 |
| 2021 | KROS | 0 | $0 | 53,000 | $3,077,225 | 110,709 | $24,364 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2022-07-15 | KROS | Option Ex | 46,034 | .30 | 13,810 |
| 2022-07-15 | KROS | Sale | 46,034 | 30.00 | 1,381,020 |
| 2022-07-13 | KROS | Sale | 1,916 | 30.00 | 57,480 |
| 2022-07-13 | KROS | Option Ex | 1,916 | .30 | 574 |
| 2022-06-14 | KROS | Option Ex | 9,400 | .30 | 2,820 |
| 2022-05-11 | KROS | Sale | 5,300 | 43.35 | 229,755 |
| 2022-05-11 | KROS | Option Ex | 5,300 | .30 | 1,590 |
| 2022-04-11 | KROS | Sale | 5,300 | 62.84 | 333,025 |
| 2022-04-11 | KROS | Option Ex | 5,300 | .30 | 1,590 |
| 2022-04-04 | KROS | Sale | 7,950 | 60.00 | 477,000 |
| 2022-04-04 | KROS | Option Ex | 7,950 | .30 | 2,385 |
| 2022-03-11 | KROS | Option Ex | 2,650 | .30 | 795 |
| 2022-03-11 | KROS | Sale | 2,650 | 53.44 | 141,623 |
| 2022-02-11 | KROS | Option Ex | 2,650 | .30 | 795 |
| 2022-02-11 | KROS | Sale | 2,650 | 52.32 | 138,640 |
| 2022-01-11 | KROS | Option Ex | 2,650 | .30 | 795 |
| 2022-01-11 | KROS | Sale | 2,650 | 53.34 | 141,351 |
| 2022-01-05 | KROS | Option Ex | 2,650 | .30 | 795 |
| 2022-01-05 | KROS | Sale | 2,650 | 60.00 | 159,000 |
| 2021-12-13 | KROS | Option Ex | 1,915 | .30 | 574 |
| 2021-12-13 | KROS | Sale | 1,915 | 51.99 | 99,560 |
| 2021-12-15 | KROS | Option Ex | 735 | .30 | 220 |
| 2021-12-15 | KROS | Sale | 735 | 50.00 | 36,750 |
| 2021-11-10 | KROS | Sale | 15,900 | 60.00 | 954,000 |
| 2021-11-11 | KROS | Sale | 5,300 | 59.26 | 314,051 |
| 2021-11-11 | KROS | Option Ex | 5,300 | .30 | 1,590 |
| 2021-11-10 | KROS | Option Ex | 15,900 | .30 | 4,770 |
| 2021-11-04 | KROS | Option Ex | 10,600 | .30 | 3,180 |
| 2021-11-04 | KROS | Sale | 10,600 | 50.00 | 530,000 |
| 2021-08-17 | KROS | Option Ex | 1,293 | .30 | 387 |
| 2021-06-24 | KROS | Option Ex | 6,500 | .30 | 1,950 |
| 2021-05-13 | KROS | Option Ex | 6,720 | .20 | 1,377 |
| 2021-05-11 | KROS | Sale | 2,650 | 50.00 | 132,500 |
| 2021-05-11 | KROS | Option Ex | 2,650 | .30 | 795 |
| 2021-04-12 | KROS | Option Ex | 5,300 | .30 | 1,590 |
| 2021-04-12 | KROS | Sale | 5,300 | 60.47 | 320,506 |
| 2021-04-01 | KROS | Option Ex | 9,996 | .11 | 1,099 |
| 2021-03-11 | KROS | Option Ex | 5,300 | .30 | 1,590 |
| 2021-03-11 | KROS | Sale | 5,300 | 64.73 | 343,053 |
| 2021-02-26 | KROS | Option Ex | 33,200 | .11 | 3,652 |
| 2021-02-11 | KROS | Option Ex | 5,300 | .30 | 1,590 |
| 2021-02-11 | KROS | Sale | 5,300 | 65.44 | 346,805 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Lachey Jennifer (Chief Scientific Officer of Keros Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.